홈 > 시장보고서 > 의료기기 > 전자의료기기

시장보고서

상품코드

1372498

신경자극 기기 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 대상 범위 : 제품별, 용도별, 최종사용자별, 지역별

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

발행일: 2023년 09월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 172 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경자극 기기 시장은 2022년 58억 200만 달러에서 2030년에는 118억 2,500만 달러에 달할 것으로 예측되고 있습니다. 이 시장은 2022-2030년 CAGR 9.3%로 성장할 것으로 추정되고 있습니다. 신경질환의 주요 발전과 척수 손상 환자의 증가가 신경자극 기기 시장 개척의 주요 원동력이 되고 있습니다. 그러나 전문가의 부족이 신경자극 기기 시장의 성장을 방해하고 있습니다.

비침습적 치료에 대한 수요 증가로 향후 신경자극기 시장 성장 전망

신경 자극은 빠르게 발전하고 있는 분야로, 신경계에 전기적, 기계적, 자기적 또는 열적 표적 자극을 주어 발화 뉴런과 내부 뉴런 결합의 특성을 변화시켜 다양한 신경 질환을 치료하는 분야입니다. 비침습적 신경 자극 장비에는 전기 경련 치료(ECT), 경피적 전기 신경 자극(TENS), 경두개 전기 자극(TES), 경두개 직류 자극(tDCS), 경두개 교류 자극(tACS), 정적 자기 자극, 무작위 소리 자극, 말초신경 자극, 초음파, 집속초음파(FUS)(뇌신경 자극 포함) 등이 있습니다. 비침습적 신경자극법은 정신의학에서 가장 발전된 방법입니다.

환자와 의료진은 편리하고 통증이 없으며 안전하고 부작용이 적은 비침습적 또는 저침습적 치료법을 선호하고 있습니다. 또한 신경계 질환에도 널리 사용되고 있습니다. 비침습적 치료는 삶의 질을 개선하고 언어, 연하 및 인지 문제의 영향을 줄이는 것을 목표로 합니다. 따라서 비침습적 치료에 대한 수요 증가는 향후 신경 자극기 시장의 성장을 크게 촉진할 것으로 보입니다.

정부가 뇌졸중에 대해 국민을 교육하고, 개선된 치료법, 의료 기술, 의료 보장 및 의료 환경을 제공합니다. 또한 중국은 비감염성 질환의 예방과 치료에 더 많은 투자를 하고 있습니다. 또한 WHO의 데이터에 따르면 중국 인구의 약 95%가 농촌과 도시에서 보험에 가입되어 있습니다. 이는 정부가 저소득층을 위한 두 가지 보험제도인 신농촌협동의료제도(NRCMS)와 도시주민기본의료보험(URBMI)을 도입한 덕분입니다. 많은 국민들에게 의료비는 큰 지출 중 하나이기 때문에 이 제도가 시작되었습니다. 중국 정부의 이러한 노력은 국민들이 건강 증진을 위해 수술을 받도록 장려하는 것입니다. 신경자극기 시장은 일본, 중국 등 의료기기 산업 시장 개척이 활발해짐에 따라 성장세를 보일 것으로 예상됩니다. 또한 신경학 분야의 혁신적인 기술 동향과 인공지능(AI) 및 머신러닝(ML)의 급속한 도입은 이 지역 시장을 촉진하는 몇 가지 요인으로 꼽힙니다.

또한 이 국가의 신경 자극기 시장의 성장은 뇌졸중 유병률 증가와 발병률 증가에 기인합니다. 신경외과수술에는 첨단 장비와 첨단 자격을 갖춘 의료 전문가가 필요합니다. 독일에는 첨단 자격을 갖춘 신경외과 전문의가 있으며, 이들은 최신 프로토콜과 수술 절차를 따르고 있습니다. 이 국가의 신경센터에는 국제 품질 기준을 충족하는 최신 진단 장비와 최소 침습 수술 장비가 있습니다.

Kings College London이 유럽뇌졸중연맹(Stroke Alliance for Europe)을 위해 실시한 'Burden of Stroke in Europe' 보고서에 따르면 독일에서는 연간 약 88,922건의 뇌졸중이 발생하고 있습니다. 인구 10만 명당 51.7건의 뇌졸중이 발생합니다. 독일의 뇌졸중 유병률은 526,774명으로 인구 10만 명당 338.5명입니다. 독일은 뇌졸중으로 인한 사망률도 높은데, i. 연간 75,861명이 뇌졸중으로 사망합니다. '유럽의 뇌졸중 부담' 보고서에 따르면 2035년까지 뇌졸중 환자가 30% 증가하고 2035년 말에는 뇌졸중 유병률이 19%까지 증가할 것으로 예상되며, 2022년 12월 독일에서 약 40만 명이 뇌졸중을 앓고 있으며, 인구 고령화로 인해 그 수가 증가할 것으로 예상됩니다. 증가 추세입니다. 젊은 층을 포함해 신경 퇴행성 질환을 앓고 있는 사람이 증가하고 있으며, 독일에서는 200만 명 이상이 치매와 파킨슨병을 앓고 있습니다. 독일 알츠하이머병 환자협회에 따르면 2020년에는 알츠하이머병으로 인한 사망자가 9450명으로 가장 많을 것으로 예상됩니다. 알츠하이머 진단으로 인한 입원 및 사망 증가는 독일의 고령화에 크게 의존하고 있습니다. 독일에서는 65세 이상 인구가 33% 증가하여 2020년에는 1,830만 명에 달할 것으로 예상됩니다.

이렇게 뇌졸중 발생률이 크게 증가하고 고령화 인구가 증가함에 따라 신경 장애 사례가 증가하고 있으며, 이는 독일 신경 자극기 시장의 성장을 촉진하고 있습니다. 또한 정부의 지원책과 신경학 연구도 시장 성장을 가속하고 있습니다. 따라서 위의 요인들은 2022-2030년 신경자극기 시장 성장에 기여할 것으로 보입니다.

신경자극기 시장은 제품, 용도, 최종사용자, 지역별로 분류됩니다. 제품별로는 척수 자극기, 뇌심부 자극기, 천골 신경 자극기, 미주 신경 자극기, 기타로 나뉩니다. 척수 자극기 부문은 2022년 큰 시장 점유율을 차지할 것으로 예상되며, 2022-2030년에는 더 높은 CAGR을 기록할 것으로 전망됩니다. 신경자극기 시장은 용도별로 통증 관리, 간질, 요실금 및 변실금, 파킨슨병, 기타로 구분됩니다. 통증 관리 분야는 2022년 큰 시장 점유율을 차지하며 2022-2030년 높은 CAGR을 기록할 것으로 예측됩니다. 신경자극기 시장은 최종사용자에 따라 병원, 전문 클리닉, 기타로 나뉩니다. 병원 부문은 2022년 시장에서 가장 큰 점유율을 차지할 것으로 예상되며, 전문 클리닉 부문은 2022-2030년 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 전문 클리닉은 높은 수준의 임상 결과를 보장하는 우수 센터입니다. 이들 센터는 신경 질환의 진단, 치료 및 관리를 전문으로 하며, 고도로 훈련된 의사, 구급대원 및 전문 기술을 갖춘 간호 인력을 고용하고 있습니다. 고급 장비를 사용하고 사전 정의된 프로토콜을 준수할 뿐만 아니라 더 나은 서비스 품질은 다른 시설보다 환자에게 더 많은 부가가치를 제공합니다. 이러한 클리닉은 서비스를 간소화하여 보다 편리한 진료를 제공합니다.

또한 전문 클리닉에서는 편안하고 차분한 환경에서 의학적으로 권장되고 관리되는 치료를 받을 수 있습니다. 이러한 클리닉은 몇 가지 진단 절차를 제공하고 파킨슨병, 알츠하이머병, 진전 등을 앓고 있는 환자의 일상적인 관리 방법에 대한 교육도 제공합니다. 이런 환자들은 질병의 중증도를 평가하기 위해 틈새 약을 복용하고 운동 증상 검사를 받을 수 있습니다. 비용 효율성과 대기 시간 단축 등의 요인이 이 부문의 성장을 가속하고 있습니다.

이러한 질환의 세계 유병률이 증가함에 따라 이러한 질환의 진단 및 치료를 위해 전문 클리닉을 방문하는 환자가 증가하고 있으며, 더 나은 치료와 전문적인 서비스를 제공하는 전문 클리닉의 수가 세계에서 증가하고 있습니다. 또한 시장 성장은 세계에서 전문 클리닉의 보급률이 증가하고 있기 때문입니다. 예를 들어 2022년 7월 오하이오 주립대 웩스너 메디컬 센터의 신경학 팀은 새로운 전문 클리닉인 파킨슨병 종합 클리닉을 개설했습니다. 이 클리닉은 파킨슨병 환자들이 여러 곳에서 여러 번 예약하지 않고도 필요한 모든 치료를 받을 수 있는 '원스톱 샵'의 역할을 합니다. 이 클리닉에서 환자들은 치료사, 신경심리학자, 전문 교육을 받은 운동신경과 전문의, 고급 실무 의료진으로 구성된 팀과 함께 경직, 기억력 장애, 어지럼증/협응력 저하, 떨림, 피로 등의 증상을 치료할 수 있습니다.

식품의약국(FDA), 국립암연구소(NCI), 보건예방부(MoHAP), 국가변혁프로그램(NTP) 등은 신경자극기 시장에 대한 보고서를 작성할 때 참고한 1차 및 2차 정보 중 일부입니다.

The neurostimulation devices market is projected to reach US$ 11.825 billion in 2030 from US$ 5.802 billion in 2022. The market is estimated to grow with a CAGR of 9.3% from 2022 to 2030. The growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the neurostimulation devices market development. However, lack of expert professionals is hampering the neurostimulation devices market growth.

Rising Demand for Noninvasive Treatment to Boost the Neurostimulation Devices Market in Future

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

The government is educating people about stroke and offering improved treatment, medical technology, and enhanced healthcare coverage and healthcare environment. Also, the country has invested more in preventing and treating noncommunicable diseases. Additionally, as per the data of WHO, ~95% of the population of China is insured in rural and urban areas, as the government introduced two insurance programs for low-income groups: the New Rural Cooperative Medical System (NRCMS) and Urban Resident Basic Medical Insurance (URBMI). The programs were launched as the cost of health is one of the significant expenses for most of the population. These initiatives by the Chinese government would encourage the population to undergo surgeries to improve health. The neurostimulation devices market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region.

Furthermore, the neurostimulation devices market growth in the country is attributed to the rising prevalence of stroke and increasing incidence. Neurosurgery requires advanced equipment and highly qualified medical professionals. Germany has highly qualified neurosurgeons; they follow the latest protocols and surgical procedures. Neurology centers in the country have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards.

According to the data published in the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, Germany records around 88,922 stroke cases annually, which is 51.7 strokes per 100,000 inhabitants. The prevalence of stroke in Germany was ~ 526,774 that accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, it is expected that stroke cases will increase by 30% by 2035, and the prevalence of stroke will grow to 19% by the end of 2035.approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 deaths were caused due to Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. In Germany, people aged 65 and above had increased by ~33% and reached 18.3 million in 2020.

Thus, significantly growing incidence of stroke and rising aging population resulting in growing cases of neurological disorders drive the neurostimulation devices market growth in Germany. Furthermore, supportive government initiatives and research in neurology also boost market growth. Therefore, the factors mentioned above are likely to contribute to the neurostimulation devices market growth during 2022-2030.

The neurostimulation devices market is segmented on the basis of product, application, end user, and geography. Based on product, the market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030. Specialty clinics are centers of excellence assured to deliver high standards of clinical outcomes. These centers are dedicated to diagnosing, treating, and managing neurological disorders and employ highly trained doctors, paramedics, and nursing personnel with specialized skills. Besides adhering to predefined protocols using high-end equipment, better service quality adds value to patients more than other facilities. These clinics streamline services and enhance convenient care.

In addition, specialty clinics provide medically recommended and supervised treatments in a relaxing and calming environment. These clinics also help to educate people regarding daily care routines for patients who have Parkinson's disease and Alzheimer's disease, tremors, and other such conditions, apart from providing several diagnostic procedures. These patients might undergo testing of motor symptoms by taking medications with gaps to assess the disease severity. Factors such as cost-effectiveness and shorter waiting times fuel the segment growth.

A global rise in the prevalence of these conditions has led to a growing number of patients visiting specialty clinics to diagnose and treat these conditions, with an increasing number of specialty clinics on the global level that offer better treatment and specialized services. In addition, the market growth is attributable to the growing penetration rate of specialty clinics across the globe. For instance, in July 2022, the neurology teams of Ohio State University Wexner Medical Center opened a new specialty clinic, the Parkinson's Disease Multidisciplinary Clinic. The clinic acts as a "one-stop shop" for Parkinson's disease patients to receive all the care they need without taking multiple appointments in different locations. At the clinic, patients can address symptoms such as stiffness, memory difficulties, unsteadiness/poor coordination, tremors, and fatigue with a team that includes therapists, neuropsychologists, subspecialty-trained movement neurologists, and advanced practice providers.

The Food and Drug Administration (FDA), National Cancer Institute (NCI), Ministry of Health and Prevention (MoHAP), and National Transformation Program (NTP) are among some of the primary and secondary sources referred to while preparing the report on the neurostimulation devices market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurostimulation devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the neurostimulation devices market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Neurostimulation Devices Market, by Geography (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Neurostimulation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Global PEST Analysis

5. Neurostimulation Devices Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Neurological Disorders
- 5.1.2 Rising Cases of Spinal Cord Injury
5.2 Market Restraints
- 5.2.1 Lack of Expert Professionals
5.3 Market Opportunities
- 5.3.1 Growing Advances and Approvals for Neurostimulation Devices
5.4 Future Trends
- 5.4.1 Rising Demand for Noninvasive Treatment
5.5 Impact Analysis

6. Neurostimulation Devices Market - Global Market Analysis

6.1 Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Spinal Cord Stimulator
- 7.3.1 Overview
- 7.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Deep Brain Stimulator
- 7.4.1 Overview
- 7.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Sacral Nerve Stimulator
- 7.5.1 Overview
- 7.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Vagus Nerve Stimulator
- 7.6.1 Overview
- 7.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Epilepsy
- 8.4.1 Overview
- 8.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Urinary and Fecal Incontinence
- 8.5.1 Overview
- 8.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Parkinson's Disease
- 8.6.1 Overview
- 8.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Specialty Clinics
- 9.4.1 Overview
- 9.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

10.1 North America: Neurostimulation Devices Market
- 10.1.1 Overview
- 10.1.2 North America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.2.1 North America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.1.2.2 North America: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.1.2.3 North America: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.1.3 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.1.3.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.3.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.3.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.1.3.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.3.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.1.3.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.3.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.2 Europe: Neurostimulation Devices Market
- 10.2.1 Overview
- 10.2.2 Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.2.2.1 Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.2.2.2 Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.2.2.3 Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.2.3 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.2.3.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.2.3.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.2.3.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.3.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.2.3.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.2.3.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.3 Asia Pacific: Neurostimulation Devices Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.3.2.1 Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.3.2.2 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.3.2.3 Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.3.3 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.3.3.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.3.3.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.3.3.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.3.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.3.3.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.3.3.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.4 Middle East & Africa Neurostimulation Devices Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.4.2.1 Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.4.2.2 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
  - 10.4.2.3 Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
- 10.4.3 Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 10.4.3.1 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.2 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.2.1 Saudi Arabia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.2.2 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.2.3 Saudi Arabia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.3 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.4 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.4.1 South Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.4.2 South Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.4.3 South Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.5 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.6 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.6.1 UAE: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.6.2 UAE: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.6.3 UAE: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.4.3.7 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.4.3.8 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.3.8.1 Rest of Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.4.3.8.2 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.4.3.8.3 Rest of Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
10.5 South & Central America: Neurostimulation Devices Market
- 10.5.1 Overview
- 10.5.2 South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.5.2.1 South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
  - 10.5.2.2 South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
  - 10.5.2.3 South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
- 10.5.3 South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
  - 10.5.3.1 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.2 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
  - 10.5.3.3 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.4 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
  - 10.5.3.5 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 10.5.3.6 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.3.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 10.5.3.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
    - 10.5.3.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)

11. Neurostimulation Devices Market-Industry Landscape

11.1 Overview
11.2 Organic Developments
- 11.2.1 Overview
11.3 Inorganic Developments
- 11.3.1 Overview

12. Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Boston Scientific Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Abbott Laboratories
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Nevro Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 LivaNova Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Synapse Biomedical Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nalu Medical, Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 ElectroCore Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 MicroTransponder Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Mainstay Medical
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 4,450

￦ 6,314,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,450

￦ 9,153,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,450

￦ 11,991,000

※ 부가세 별도

신경자극 기기 시장 규모 및 예측, 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 대상 범위 : 제품별, 용도별, 최종사용자별, 지역별

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 신경자극 기기 시장 구도

제5장 신경자극 기기 시장 - 주요 산업 역학

제6장 신경자극 기기 시장 : 세계 시장 분석

제7장 신경자극 기기 세계 시장 : 2030년까지의 매출과 예측 : 제품별 분석

제8장 신경자극 기기 세계 시장 : 2030년까지의 매출과 예측 : 용도별 분석

제9장 신경자극 기기 세계 시장 : 2030년까지의 매출과 예측 : 최종사용자별 분석

제10장 신경자극 기기 세계 시장 : 2030년까지의 매출과 예측 : 지역별 분석

제11장 신경자극 기기 시장 - 업계 상황

제12장 기업 개요

제13장 부록